의약품 관련 법령
Addendum I of 14-Sep-2018 to the Off-Label Use Expert Group Final Report of 13-Jul-2018: On the Use of Amantadine in Patients with Multiple Sclerosis in the Treatment of Fatigue
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-09-18 | 조회수 | 899 |
| 국가정보 | 유럽>독일 | ||
| 출처 | BfArM | ||
| 원문 | ww.bfarm.de | ||
| 첨부파일 | |||
On the Use of Amantadine in Patients with Multiple Sclerosis in the Treatment of Fatigue.pdf(52.77KB)Addendum I of 14-Sep-2018 to the Off-Label Use Expert Group Final Report of 13-Jul-2018: On the Use of Amantadine in Patients with Multiple Sclerosis in the Treatment of Fatigue
- 이전글 Evaluation Report: Drug Not Approval Document of VIBERZI (Eluxadoline)
- 다음글 Announcement of 17-Sep-2018: On Amendments According to §5 of the Decree on Determination and Labeling of Pack Sizes for Medicinal Products
